{{-- --}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode'])) Logout @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf

Survey to assess corticosteroid usage patterns in Indian Patients

Doctor’s details
@if(isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. In a month how many patients with following conditions are consulted by you? (You can answer in range) *
  2. Condition No. of patients/month
    Bronchial Asthma
    Seasonal or perennial allergic rhinitis
    Rheumatoid Arthritis
    Atopic dermatitis
  3. What is the age of bronchial asthma patients you see in your clinical practice in a month? (You can answer in range) *
  4. Paediatric
    Adolescent
    Adult
    Geriatric
  5. Out of your total bronchial asthma patients approximately what percent of patients are…? *
  6. Less than age 12 years
    Between age 12 to 17 years
    Age 18 and 65 years
    Above 65 years of age
  7. What percentage of your patients to whom you prescribe systemic corticosteroids have comorbid conditions like hypertension, diabetes mellitus, and obesity? *
  8. What % of your patients are treatment naïve to corticosteroids? *
  9. In your clinical practice what is most common trigger for allergic rhinitis? *
  10. In your clinical practice what is most common trigger for bronchial asthma? *
  11. Which of the following medications are commonly used by you for initial control of symptoms in your patients with allergic rhinitis? *
  12. What is your preferred dosage of methylprednisolone in allergic rhinitis? *
  13. When do you use systemic corticosteroids in patients with allergic rhinitis and for what duration? *
  14. When do you use systemic corticosteroids in patients with bronchial asthma and for what duration? *
  15. When do you use systemic corticosteroids in patients with Rheumatoid arthritis and for what duration? *
  16. Do you evaluate patients on the RASS (rheumatoid arthritis severity scale)? *
  17. Do you continue corticosteroids as maintenance therapy in bronchial asthma? *
  18. What method do you follow to taper methylprednisolone? *
  19. In what situations do you prefer IV corticosteroids over oral therapy? *
  20. How often do you encounter steroid withdrawal symptoms? *
  21. How do you manage steroid withdrawal symptoms? *
  22. What technology (mobile applications, web portals, or other mobile, online, or digital tools) do you leverage to manage bronchial asthma patients? *
  23. In which other Respiratory conditions, you choose to use methylprednisolone? *
  24. In which of the following conditions do you choose to use methylprednisolone? (Please select more than one option if applicable.) *
  25. For which of the following rheumatic disorders do you choose to use methylprednisolone as adjunctive short-term therapy? (Please select more than one option if applicable.) *
  26. For which collagen disorders do you choose to use methylprednisolone as adjunctive short-term therapy? (Please select more than one option if applicable.) *
  27. How do your patients on methylprednisolone respond to bronchial asthma? *
  28. Overall based on real-life experience how do patients on methylprednisolone respond in pain & inflammation in arthritis? *
  29. How do you rate the tolerability of methylprednisolone? *
  30. How long does methylprednisone typically take to show effect? *
  31. Rate Methylprednisolone for the following parameters compared to Prednisolone & Deflazacort. *
  32. Rate on a scale of 5 to 1 (5 being best or highest and 1 being worst or lowest)
    Parameters Methylprednisolone Prednisolone Deflazacort
    Efficacy
    Safety
    Tolerability
    Dosage flexibility
    Quality of Life
  33. What are the advantages of Methylprednisolone over existing corticosteroids? *
  34. Mention the parameters and describe the advantages of Methylprednisolone over Prednisolone & Deflazacort on those parameters.

  35. Preferred indications for given below corticosteroids *
  36. Methylprednisolone Prednisolone Deflazacort

  37. What educational resources or materials do you provide patients to enhance their understanding of allergic conditions such as asthma, allergic rhinitis? *
  38. Do you utilize patient-reported outcomes (e.g., symptom severity scales, quality of life assessments) to evaluate the impact of allergic conditions such as asthma, allergic rhinitison patients' daily lives? *